sur RedChip Companies, Inc. (Media Suite) (NASDAQ:JUNS)
BioVie and FibroBiologics Feature on RedChip Show on Bloomberg TV
RedChip Companies announced that it will broadcast interviews with BioVie Inc. and FibroBiologics, Inc. on its show, "Small Stocks, Big Money™," airing on Bloomberg TV on September 27. The program, reaching approximately 73 million U.S. homes, will feature insights from both companies' CEOs.
Cuong Do, President and CEO of BioVie, will discuss the potential of bezisterim (NE3107), targeting Alzheimer's, Parkinson's, and Long COVID. He will also detail BIV201, designed for refractory ascites in liver cirrhosis. BioVie's programs are advancing with strong clinical data and market potential.
Pete O'Heeron, CEO of FibroBiologics, highlights the company's fibroblast-based therapies in their robust pipeline, including CYWC628 for diabetic foot ulcers. They aim for large markets with over 240 patents supporting their scalable platform.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de RedChip Companies, Inc. (Media Suite)